SUSAN KELONE: Open Payments
NPI 1497743645 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 68 payments from 18 companies in 2025. Trend: 2023 $853 · 2024 $1,099 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $208 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| Novo Nordisk Inc | 10 | $169 |
| Lilly USA, LLC | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $58 |
| Exact Sciences Corporation | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: REXULTI, FARXIGA, QULIPTA, JARDIANCE, Ozempic, MOUNJARO, UBRELVY, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
